Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
Authors
Keywords
-
Journal
World Psychiatry
Volume 14, Issue 3, Pages 339-347
Publisher
Wiley
Online
2015-09-26
DOI
10.1002/wps.20252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study
- (2015) Christoph U. Correll et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Inflammation, Obesity, and Metabolic Syndrome in Depression
- (2014) Chad D. Rethorst et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacologic and Behavioral Interventions to Improve Cardiovascular Risk Factors in Adults With Serious Mental Illness
- (2014) Jennifer M. Gierisch et al. JOURNAL OF CLINICAL PSYCHIATRY
- Unraveling the Mechanisms Responsible for the Comorbidity between Metabolic Syndrome and Mental Health Disorders
- (2014) Elizabeth K. Nousen et al. NEUROENDOCRINOLOGY
- Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
- (2014) Ulrich Reininghaus et al. SCHIZOPHRENIA BULLETIN
- Markers of inflammation in schizophrenia: association vs. causation
- (2014) Peter Manu et al. World Psychiatry
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
- (2013) Francesco Bartoli et al. AMERICAN JOURNAL OF PSYCHIATRY
- Response to Bartoli et al.
- (2013) Davy Vancampfort et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
- (2013) Davy Vancampfort et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population
- (2013) Michael J Bly et al. BIPOLAR DISORDERS
- Cigarette Smoking Among Persons With Schizophrenia or Bipolar Disorder in Routine Clinical Settings, 1999–2011
- (2013) Faith Dickerson et al. PSYCHIATRIC SERVICES
- Antidepressant use and glycemic control
- (2013) Ramin Mojtabai PSYCHOPHARMACOLOGY
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
- (2013) D. Lawrence et al. BMJ-British Medical Journal
- Avoidable mortality in people with schizophrenia or bipolar disorder in England
- (2012) U. Hoang et al. ACTA PSYCHIATRICA SCANDINAVICA
- Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis
- (2012) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- The Intersection Between Aging and Cardiovascular Disease
- (2012) Brian J. North et al. CIRCULATION RESEARCH
- Glucose Metabolism and Antidepressant Medication
- (2012) Johannes M. Hennings et al. CURRENT PHARMACEUTICAL DESIGN
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
- (2012) F Lamers et al. MOLECULAR PSYCHIATRY
- Trends in Use of Second-Generation Antipsychotics for Treatment of Bipolar Disorder in the United States, 1998–2009
- (2012) Jessica Pillarella et al. PSYCHIATRIC SERVICES
- Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia
- (2012) Davy Vancampfort et al. PSYCHIATRY RESEARCH
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
- (2012) A. J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia
- (2011) Davy Vancampfort et al. DISABILITY AND REHABILITATION
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
- (2011) Chin-Kuo Chang et al. PLoS One
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
- (2010) Alex J Mitchell et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
- (2009) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search